Genetics field trip! In this episode we hopped in Jenny's car and headed to Vertex Pharmaceuticals where we spoke with Chief Scientific Officer, David Altschuler. Previously, as a core member of the Broad Institute, David's academic research focused on using human population genetics to identify therapeutic targets for complex diseases. In our conversation, David tells us about his transition into industry and how his former research strategy now informs his scientific vision at Vertex Pharmaceuticals.